Filing Details

Accession Number:
0000874015-19-000135
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-21 18:38:50
Reporting Period:
2019-11-20
Accepted Time:
2019-11-21 18:38:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1537529 P Brett Monia C/O Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Coo & Svp, Translational Med Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-20 5,776 $60.01 16,458 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale of shares owned was made pursuant to a 10b5-1 Trading Plan adopted by the reporting person on 10/7/2019.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.01, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.